Steward Partners Investment Advisory’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-540
Closed -$95K 2826
2020
Q1
$95K Sell
540
-1,034
-66% -$195K ﹤0.01% 1013
2019
Q4
$301K Buy
1,574
+627
+66% +$113K 0.01% 762
2019
Q3
$159K Sell
947
-302
-24% -$49.2K 0.01% 919
2019
Q2
$209K Sell
1,249
-8,392
-87% -$1.16M 0.01% 805
2019
Q1
$1.41M Sell
9,641
-3,626
-27% -$526K 0.06% 290
2018
Q4
$1.77M Buy
13,267
+4,685
+55% +$768K 0.09% 241
2018
Q3
$1.64M Sell
8,582
-53
-0.6% -$9.74K 0.08% 254
2018
Q2
$1.44M Sell
8,635
-9,092
-51% -$1.46M 0.09% 236
2018
Q1
$2.98M Buy
+17,727
New +$2.97M 0.2% 115

Other funds holding AGN

Steward Partners Investment Advisory's AGN Position: Q2 2020 in Review

Steward Partners Investment Advisory sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 540 shares — an estimated $95K sold.

Steward Partners Investment Advisory first reported a position in AGN in Q1 2018 and held it in 9 quarters. The position peaked at $2.98M in Q1 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Steward Partners Investment Advisory reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 540 Allergan plc shares in Q2 2020, an estimated $95K.
  • Steward Partners Investment Advisory first reported a position in Allergan plc in Q1 2018 and held it in 9 quarters.
  • Steward Partners Investment Advisory's Allergan plc position peaked at $2.98M in Q1 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2020, filed 6 Aug 2020.